Ackman's Pershing Square Confirms Liquidating Valeant Pharma (VRX) Stake
Tweet
Share
E-mail
In an amended 13D filing, Bill Ackman's Pershing Square confirm liquidating their Valeant Pharma (NYSE: VRX) stake.
"“The Reporting Persons on behalf of the Pershing Square Funds: (i) sold 18,114,432 shares of Common Stock, (ii) unwound 91,200 (with 100 multiplier) listed American-style call options with a strike price of $60.00, and (iii) unwound 9,120,000 over-the-counter European-style put options with a strike price of $60.00 (together, the “Sale”)."
Exhibit 99.15
Name | Trade Date | Buy/Sell/Exercise | No. of Shares / Quantity | Unit Cost | Strike Price | Trade Amount | Security | Expiration Date | ||||||||||||||||||
Pershing Square International, Ltd. | March 13, 2017 | Sell | 6,697,420 | $ | 11.00 | N/A | $ | 73,671,620 | Common Stock | N/A | ||||||||||||||||
Pershing Square International, Ltd. | March 13, 2017 | Buy to Close | 2,696,233 | $ | 47.65 | $ | 60.00 | $ | 128,475,502 | OTC Put Option | January 18, 2019 | |||||||||||||||
Pershing Square International, Ltd. | March 14, 2017 | Sell to Close | 26,962 | $ | 0.30 | $ | 60.00 | $ | 807,680 | Listed Call Option | January 18, 2019 | |||||||||||||||
Pershing Square, L.P. | March 13, 2017 | Sell | 2,605,653 | $ | 11.00 | N/A | $ | 28,662,183 | Common Stock | N/A | ||||||||||||||||
Pershing Square, L.P. | March 13, 2017 | Buy to Close | 2,114,586 | $ | 47.65 | $ | 60.00 | $ | 100,760,023 | OTC Put Option | January 18, 2019 | |||||||||||||||
Pershing Square, L.P. | March 14, 2017 | Sell to Close | 21,146 | $ | 0.30 | $ | 60.00 | $ | 633,455 | Listed Call Option | January 18, 2019 | |||||||||||||||
Pershing Square II, L.P. | March 13, 2017 | Sell | 31,229 | $ | 11.00 | N/A | $ | 343,519 | Common Stock | N/A | ||||||||||||||||
Pershing Square II, L.P. | March 13, 2017 | Buy to Close | 67,844 | $ | 47.65 | $ | 60.00 | $ | 3,232,767 | OTC Put Option | January 18, 2019 | |||||||||||||||
Pershing Square II, L.P. | March 14, 2017 | Sell to Close | 678 | $ | 0.30 | $ | 60.00 | $ | 20,310 | Listed Call Option | January 18, 2019 | |||||||||||||||
Pershing Square Holdings, Ltd. | March 13, 2017 | Sell | 8,780,130 | $ | 11.00 | N/A | $ | 96,581,430 | Common Stock | N/A | ||||||||||||||||
Pershing Square Holdings, Ltd. | March 13, 2017 | Buy to Close | 4,241,337 | $ | 47.65 | $ | 60.00 | $ | 202,099,708 | OTC Put Option | January 18, 2019 | |||||||||||||||
Pershing Square Holdings, Ltd. | March 14, 2017 | Sell to Close | 42,414 | $ | 0.30 | $ | 60.00 | $ | 1,270,564 | Listed Call Option | January 18, 2019 | |||||||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- D.E. Shaw owns $1B+ stake in Sysco - Reuters
- Pershing Square Inc. Reports Second Quarter 2026 Results
- Activist Ancora Now Seeks to Buy H.B. Fuller Adhesives Unit - Bloomberg
Create E-mail Alert Related Categories
13Ds, Hedge FundsRelated Entities
William Ackman, Pershing Square Capital, 13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
